Drug Rehab Facility Sausalito is ready to assist you on your Road to Recovery.
Call Drug Rehab Sausalito now to start your intake process.
Fear and apprehension are often the greatest challenges to rehabilitation, which is usually a long and challenging task that will more than likely require help from professionals. Obtaining the appropriate support and professional help, you can overcome your substance abuse problem.
At Drug Rehabilitation Facility Sausalito we have a full spectrum of addiction treatment programs to clients that come to our rehab center struggling with addiction problems. Clients that become addicted to substances like percocet, vicodin, lortab, heroin, meth and other substances that cause addiction usually don't know how to recover by themselves without help. We have provided help to countless individuals to beat their addiction with our comprehensive rehabilitation methods.
The initial step of our program is our detox regimen. After an individual has used an addictive drug over an extended period of time a physical dependence occurs and takes over. When dependence or addiction has developed it is often unsafe to abruptly discontinue use without professional assistance from a medically monitored detoxification procedure. Addictive drugs such as alcohol, valium, heroin, meth, demerol, fentanyl and others produce a wide variety of withdrawal effects such as agitation, anxiety, muscle aches, insomnia, sweating, vomiting, diarrhea, cramping, nausea and other symptoms.
At Drug Rehabilitation Facility Sausalito we offer the often necessary medical supervision to make our clients as comfortable as possible in the detox period. We offer 24 hour care and support throughout this crucial first phase in the rehabilitation process. Program participants often say that they feel a renewed sense of hope once they have completed our detoxification process.
A vital step in overcoming addiction is to acknowledge that you have a problem. An individual who refuses to accept they are addicted cannot take strides to fix the problem they deny they have. For many, when it comes down to confronting their addiction situation, along with that requires also to look at how and why they got addicted in the first place. Addiction often happens when someone uses a substance to relieve physical and/or emotional pain in order to minimize negative feelings and emotions. If an individual doesn't recognize the underlying issues fueling their addiction and does not accept help, it will typically be extremely difficult for them to overcome their addiction.
Acknowledging that you have a problem is an extremely important part of recovery from alcohol addiction or drug abuse. However you must also have the desire to do what is needed to change it. Taking inventory of the reasons for making a change will help you navigate the road to rehabilitation. Many people find it helpful to write down why they want to change. Reasons could include wanting to be a better parent, experience more joy in life, to be the person you really want to be, repair relationships with family and friends, to improve your health, or to simply repair the damage that addiction causes.
Do not only concentrate and be absorbed on the circumstances and problems caused by your addiction, because focusing in on the negative consequences of the past can make you feel depressed and hopeless. Instead, focus on your new addiction-free life and the recovery process. Focus on the positive things that will surely happen when you have recovered from addiction. At Drug Rehab Center Sausalito we will help you to embrace your prospects for a happy, productive, addiction-free life. A future accomplishing long lost goals and dreams in your newly created addiction-free life. You will be healthier, have more energy and enthusiasm, be more secure financially, have lasting relationships, be more productive at work, and have time to enjoy and explore new hobbies and recreation. Setting aside time to list out these goals can keep you motivated during the recovery process.
At Drug Treatment Facility Sausalito we know that the most important factor in determining success is whether the patient has truly overcome their addiction to drugs. Success can only be determined by the patient's belief in their ability to remain clean and sober. Short term treatment programs typically fall short of this goal.
We know that it is very important not to be under time restraints when in treatment. The time that you spend in treatment can offer a lifetime of sobriety, it is definitely worth the investment of whatever time that it requires. We locate the underlying reasons that that most likely are at the root of the addiction. We will help you to fix the damages that you have caused in your life so that you are not filled with shame and regret. You will be taught life skills, coping skills and relapse prevention methods so that you are not just sober when you leave, but know how to stay sober for the rest of your life. We know that you want your life back and we are here to help you find a way to achieve it.
The only person who can change you is you. At Drug Rehab Center Sausalito it helps to be immersed in a strong support network to help you succeed. That said, hold onto the people in your life that are supportive and positive. Conversely, be cautious about retaining the unsupported and negative relationships in your life, like past associates that still use drugs, or relationships with people that make you feel incapable or inadequate.
Detoxification is only the initial phase in a long process of rehabilitation at Drug Rehabilitation Program Sausalito; But will also help you to recognize the triggers of your addiction cravings. Stress, anxiety, fear, deficiencies in confidence etc. are all triggers for substance abuse. Learning healthy relapse prevention skills will help you to push away and overcome the urge to use drugs. Our facility activities include exercise, nutrition, drug education, cognitive education therapy, coping skills, life skills, craving and relapse prevention education and training.
At Drug Rehabilitation Center Sausalito, we have helped thousands of people beat addiction.
Copyright © 2010 | www.drugrehabsausalito.com | All rights reserved.


Dive Rutland are pleased to be able to support our local Open water swimmers and budding Triatheletes by now stocking a full size range of the Aqua Sphere Pursuit Full Sleeve Triathlon Wetsuit.
A suit geared for the "weekend warrior and beginner triathlete." The Pursuit retails for £189.99 and is a great wetsuit with a great price.
The Aqua Sphere Wetsuit is Flexible: Aqua Sphere's bio-stretch zone suit posses thin wrap-around reach panels that are engineered and designed to follow the natural movements of a swimmer's shoulders, upper body, and core rotation while swimming.
The Aqua Sphere Wetsuit is Warm: A wetsuit, after all, should keep the swimmer or the tri-athlete warm in the water. Sadly, many wetsuits can't even claim to do that. Aqua Sphere incorporates Thermo-Guard technology into all of its products. According to field tests, the Aqua Sphere Pursuit provides maximum warmth, maximum flexibility, and maximum range of motion in the shoulders, legs, and chest areas.
The Aqua Sphere Wetsuit has Aqua Drive Technology: The wetsuit's panels are strategically placed around the core of the body. This acts as a primary planning surface while swimming. The Aqua Drive Technology is engineered and designed to maximize buoyancy and efficiency. Many tri-athletes, beginners and advanced alike, reported the Aqua Drive Technology resulted in an improved body position that reduces drag and increases hydrodynamics.
The Aqua Sphere Wetsuit has an Aqua-Flex Collar: To a tri-athlete, nothing is more uncomfortable than a tight, itchy collar. Aqua Sphere's Aqua-Flex collar is watertight and comfortable. It has two layers with an ultra-fine nano-skin design which minimizes neck chaffing.
Aqua Sphere Incorporates Top-Of-The-Line Nanotechnology: #38 Yamamato nanotechnology offers the optimum balance of reduced drag, flexibility, and durability, The SCS nano-skin coating has the absolute lowest drag coefficient available on the market and it maximizes speed and performance.
Overall, the Aqua Sphere Pursuit Full Sleeve Triathlon Wetsuit is a great wetsuit for the price. It's warm, it's stretchy, it offers 100% UVA/UVM protection, and it's quick drying. One of the things many people like about the Aqua Sphere is the zip. Although a zip might seem like a tiny detail, nothing is more annoying to a triathlete than a hard-to-reach or hard-to-unzip zip. You could lose precious seconds, even minutes, if you have a troublesome zip. Aqua Sphere's durable, deep-back pull zip offers a leash for easy on/off and quick transitions. Those who have reviewed the Aqua Sphere, couldn't believe how easy it was to unzip and get in and out of it. The Aqua Sphere Pursuit is one of the best triathlon wetsuits for a triathlete on a budget.
So stop by have a look and a try on, or if you would like us to bring samples to your club meetings or events please do let us know and we would be happy to come along.


text:
Gardhiwala is een nagar panchayat (plaats) in het district Hoshiarpur van de Indiase staat Punjab.

Demografie
Volgens de Indiase volkstelling van 2001 wonen er 6.263 mensen in Gardhiwala, waarvan 52% mannelijk en 48% vrouwelijk is. De plaats heeft een alfabetiseringsgraad van 79%.

Plaats in Hoshiarpur

redpajama_set_name: RedPajamaWikipedia


Classic Pac Man. Arrow key control.
Mesazh jp ( 18 Korrik 2008 00:49) : Message from the author : "My version of Pac-Man is no longer available on Neave Games due to its perceived misuse of Namco's copyright and trademark. I'm very sorry about that. "


text:
Free Case Consultation (202) 618-9898
Criminal Violations
Washington DC Criminal Defense Attorney
Facing a criminal charge in Washington, DC? Consult with DC defense attorney Shawn Sukumar for help today.
Free Consultation Meet Shawn
DC DUI License Suspension
Washington, DC has an unusual system in which the criminal penalties for driving under the influence case are separate from the possible driver's license penalties of the DC DMV. The criminal judges in DC only have control over whether a person is convicted of a DUI at trial and any sentencing conditions including jail time, probation, fines, or a combination of those. However, DC judges have no control over the suspension or revocation of a person's driver's license; that is handled as a separate matter by the DC DMV.
When someone is arrested for driving under the influence, they receive two forms. The first form tells them when they must appear before the criminal judge for an arraignment on their criminal case. The other form is the official notice of proposed revocation. This is a notice from the DC DMV saying that a person is eligible for mandatory license revocation because they were arrested for a DUI. If your license has been suspended for a first time DUI in DC, an experienced DUI lawyer can discuss your next steps in order to plan the appropriate defense for you and your future.
Revocation of the License
For a first offense DUI, the mandatory license revocation is six months in DC. The District does not have restricted licenses or limited licenses because the DC DMV rules are strictly written. There is no leeway in the six month period for license suspension and there are no exceptions. A first time DUI in DC has a flat six months revocation period.
When someone has a DC driver's license, the DC DMV can physically take their license and revoke their driving privileges for the full six months after a first-time DUI arrest. A person who does not have a DC driver's license is only eligible to have their DC driving privileges revoked for six months. The DC DMV cannot revoke a person's full driver's license when they do not have a DC driver's license.
However, a revocation of a non-DC driver's license privileges after a DUI charge in the District can be transferred to a person's home state. Their home state could take action against their driver's license based on that state's rules. When an individual receives a notice of license revocation from the DC DMV; the form tells them they have a specific window of time in which to schedule a hearing with the DC DMV to challenge the proposed revocation.
Requesting a Hearing
If a person has a DC license, they have a 10-day period to request a hearing. When someone has a non-DC license, they have 15 days. In either case, the person must go to the DC DMV adjudication department to schedule the DMV hearing in person. At the hearing, the DC DMV could hear testimony separately from the DC criminal case. The DC DMV makes a determination as to whether that person's driving driver's license or driving privileges in DC are revoked.
If the DMV does not hear sufficient evidence to revoke someone's driver's license or driving privileges in DC, the DMV can wait for the outcome of the criminal case. If the person is convicted, they face the same mandatory loss of driving privileges. If a person is not convicted, the DC DMV might take no action against their driving privileges.
A person who is arrested for a first time DUI in DC has 10 or 15 days to schedule a hearing to challenge the proposed revocation of their license. When a person schedules the hearing, their driving privileges are placed on a pending suspension or pending revocation status.
Challenging License Suspension
Driving privileges are not affected during the 10 or 15 day period after the DUI. If the DC DMV hears enough evidence at the hearing to conclude that the person was driving under the influence, the DMV takes action against their driver's license and imposes the mandatory six-month license revocation period. If a person is alleged to have refused to provide a sample of breath, blood, or urine after being arrested, they are eligible for a mandatory one-year DUI license suspension.
At the hearing, the person can challenge the evidence against them and argue to have the DMV not impose that revocation. The DMV's only consideration for revocation of the DUI license suspension is the evidence in the person's case. A person cannot have a restricted permit and cannot argue that their license should not be revoked because it is a burden. Anyone wanting to challenge the suspension of their license after a DC DUI charge should contact a DUI lawyer who can assist in their case.
DC Criminal Lawyer
Shawn Sukumar Attorney at Law
1826 Jefferson Pl NW
If charged with a criminal offense in Washington DC the consequences can be serious. Please contact our office today for a free consultation.
DC DUI Lawyer
DC Assault Lawyer
DC Drug Lawyer
Copyright © DC Criminal Lawyer 2021. All Rights Reserved.

redpajama_set_name: RedPajamaCommonCrawl


text:
How Much is the Metal Gear Video Game Franchise Worth?
Nat Berman 1 year ago
Metal Gear is a long-running Konami series of action-adventure games that put a strong emphasis on stealth. Generally speaking, the Metal Gear games are focused on special forces operatives who will come upon one of the bipedal tanks called "Metal Gears" at some point on their missions, but there have been exceptions as well. For example, Metal Gear Rising: Revengeance was focused on a ex-special forces operative turned mercenary cyborg fighting other mercenary cyborgs. Likewise, Metal Gear Survive was focused on a customizable player-character attempting to survive in a forlorn land filled with what are best-described as nanomachine zombies. Regardless, the Metal Gear series is famous, not least because it blends in movie references, philosophical themes, and its own weird sense of humor.
What Is the Value of the Metal Gear Franchise?
For those who are curious, the Metal Gear series started up with Metal Gear in 1987 before following up on it with Metal Gear 2 in 1990. Later, the series moved on with Metal Gear Solid, which in turn, led to a total of five main installments as well as a number of spin-offs. The last example was Metal Gear Solid V: The Phantom Pain, which came out in 2015.
Chronically, the Metal Gear series is something of a mess. For example, both Metal Gear and Metal Gear 2 were focused on Solid Snake, who went on to star in other Metal Gear games culminating in Metal Gear Solid: Guns of the Patriots where he went under the code-name Old Snake. However, Metal Gear Solid 3: Snake Eater was focused on Naked Snake, who was the person that Solid Snake was cloned from as well as at various points in time, both his commander and his eventual nemesis. Meanwhile, Metal Gear Solid V: The Phantom Pain was focused on Venom Snake, who was presented as being Naked Snake with a separate code-name but turned out to be one of Naked Snake's subordinates who had received extensive cosmetic procedures to turn him into a double for Naked Snake following an incident that took out both of them. Summed up, release order isn't the same as chronological order for the Metal Gear series, which is something that has been known to cause confusion for newcomers to it.
Based on the fact that Metal Gear Solid V: The Phantom Pain came out in 2015 and Metal Gear Survive came out in 2018, it should come as no surprise to learn that the Metal Gear series has been rather successful, thus explaining its staying power. For instance, each of the various Metal Gear Solid games have managed to sell multiple millions of copies, with Metal Gear Solid 2: Sons of Liberty selling more at 7 million copies and Metal Gear Solid 3: Snake Eater selling less at 6 million copies while the other sold around 6 million copies each. Furthermore, the characters of the Metal Gear series are some of the most iconic that can be found in the video game market, which is why Solid Snake had a short cameo in Ready Player One and is set to make a return to Nintendo's Super Smash Bros. series with Super Smash Bros. Ultimate.
Unfortunately, the Metal Gear series has run into some serious issues in recent times. In short, there was a serious falling-out between Konami and the series creator Hideo Kojima during the making of Metal Gear Solid V: The Phantom Pain. Exactly what happened is unknown, which hasn't been helped by unconfirmed rumors such as how Kojima was barred from picking up the win for Best Action Game at the 2015 Game Awards by Konami. However, whatever happened, it is clear that the two parties have parted ways, which has resulted in a fair amount of anger from the Metal Gear fan base directed at Konami. Combined with the fact that Metal Gear Survive was nowhere near the success that Konami presumably wanted, the future of the Metal Gear series is rather uncertain at the moment.
Still, this isn't to say that the Metal Gear series has no remaining power to it. For example, there is a Metal Gear movie being worked upon at the moment, though it remains to be seen whether this particular attempt will beat its predecessors by actually getting filmed. Likewise, there is still a lot of Metal Gear merchandise being made, which is without counting potential Metal Gear games that could still be made in the future. Due to this, it is safe to say that the Metal Gear is still a multi-million series in spite of the recent hits that it has taken.
Nat Berman
Nat is the Founder and Editor in Chief of Uncoached Corporation and all its properties. His primary roles are managing editorial, business development, content development, online acquisitions, and operations.Uncoached began in 2007 with one site and a goal of creating content that was clear, concise, worth reading, entertaining, and useful. Since then the portfolio has grown to 8 properties covering a wide array of verticals including business, personal finance, real estate, architecture, television, movies, entertainment, video games, lifestyle, pets, and more.
Echo Nest: The One Company That May Change the Music Industry Forever
Musical Acts That Will Gross the Most Money in 2016
How to Get Paid To Tweet About Summer Music Festivals
Why It Costs Some Animation Shows Up To $2 million To Make A Single Episode
Need Proof that Cable TV is Dying? This One Stat Trumps Them All
Exactly How Valuable is the Assassin's Creed Franchise?
Nat Berman May 17, 2016
Echo Nest: The One Company That May …
Musical Acts That Will Gross the Most …
How to Get Paid To Tweet About …
Why It Costs Some Animation Shows Up …
Need Proof that Cable TV is Dying? …


text:
Paws and Effect: New Breeds of Assistance Animals Bring Challenge and Opportunity
In January, a performance artist with an "emotional support peacock" was denied entry for a flight on United Airlines out of Newark Airport. The owner brought the bird to the airport, arguing that she purchased a ticket for him, but the airline said it had repeatedly warned her in advance that they could not safely make such an accommodation. Dexter the peacock never got to fly, and while his case has widely been accepted as an overreach on the part of his owner, the feathers ruffled by his story will have a real and lasting impact.
Airlines have seen a massive surge in assistance animals: Delta carried approximately 250,000 service or emotional support animals with its 180 million passengers last year, and United Airlines reported a 76% rise in passengers traveling with emotional support animals, from 43,000 in 2016 to 76,000 in 2017. While serious incidents are exceedingly rare, those that occur make headlines and, as the overall number of animals increases, the number of such problems has as well.
The growing adoption has acculturated many Americans to seeing all kinds of assistance animals, but evolving perspectives of what constitute legitimate uses have introduced challenges for customers and companies alike. With easy ways to obtain a letter of need online, for example, many people have begun to present their pets as emotional support animals in order to work around travel restrictions and avoid the fees typically charged to transport a pet.
This can cast reasonable doubt on claims about the need for an assistance animal, particularly with the "alternative" animals like pigs, rabbits and ducks that have drawn notable media attention. In response, the top U.S. airlines have been revisiting and refining their policies for travelers and implementing new controls to balance compliance, customer welfare and reputation risks with the potential for disruption, property damage, and safety and sanitation issues for other customers and employees. United had reportedly been reviewing its policy on accommodating assistance animals since last year, but the attention Dexter drew prompted the airline to release new policy provisions, as did Delta and American Airlines. The Department of Transportation reportedly plans to propose new official rules later this year.
Delta's new rules, implemented March 1, include clear, basic risk management provisions. Those traveling with service or comfort animals must provide documentation of the safety and necessity of the animal 48 hours before departure and provide a veterinary health form or vaccination record. For comfort and psychiatric service animals, passengers must also provide a letter signed by a doctor or licensed mental health professional stating the passenger's need for the animal and a signed letter attesting that the animal is trained to behave without a kennel.
Different Classes of Assistance Animals
Much of the confusion comes from the varied terms and classes of assistance animals. The only animals covered by Title II and Title III of the Americans with Disabilities Act are service animals, defined as "any dog that is individually trained to do work or perform tasks for the benefit of an individual with a disability, including a physical, sensory, psychiatric, intellectual, or other mental disability." These are almost exclusively dogs, although some miniature horses also qualify. The work performed by a service animal must be directly related to the individual's disability, such as guide or Seeing Eye dogs for those with severe visual impairments, hearing or signal dogs for those with significant hearing loss or deafness, SSigDOGs (sensory signal or social signal dogs) specifically trained to assist people with autism, seizure response dogs, and psychiatric service dogs specifically trained to perform tasks that detect the onset or minimize the effect of psychiatric episodes for those with conditions like PTSD or dissociative identity disorders.
Psychiatric service animals are not the same as emotional support or comfort animals, which are not considered service animals under the ADA. Emotional support animals may, however, be covered by other regulations, such as the Air Carrier Access Act (ACAA), or local ordinances, and as such may either merit or require accommodation as well. Emotional support or comfort animals are often used as part of their owner's medical treatment plan, such as in the treatment of acute anxiety or depression, and there is no formal standard of training required for these animals.
Unlike emotional support or comfort animals, which are intended to benefit their owner, therapy animals are certified through individual organizations to go out with their owner to help comfort and give companionship to groups of other people. This is typically done in clinical settings, like hospitals, schools or even airport outreach programs, with the aim of aiding physical, social, emotional or cognitive functioning. Animals used are primarily dogs, but can also include miniature horses, cats, rabbits and guinea pigs. Therapy organizations require certain standards of obedience training and temperament, but there is no official overall standard. These animals often wear identifying vests or bandanas, which may make them look similar to service dogs, but this does not translate into the same legal requirements for accommodation. Rather, they are allowed inside a given facility because they are specifically invited for a therapy visit there.
Developing ADA-Compliant Policies
When it comes to establishing compliant policies for the accommodation of assistance animals, the ADA makes one point very clear: facilities open to the public must accommodate a service animal working with the individual it serves, and cannot deny or alter service, including charge additional fees, for an individual with a disability and a service dog. Under the ACAA, a legitimate assistance animal must pose a direct threat to the health or safety of others to be denied accommodation—phobia or allergy are not sufficient problems, although companies are certainly free to offer alternative accommodation to a customer who expresses such objections. If it is evident the dog is working as a service dog, such as a Seeing Eye dog guiding a blind person, employees should not request or require further clarification. In most situations, documentation, paperwork, license or certification cannot be required as proof that a dog is a service dog. Such documentation can, however, be required for a therapy or emotional support animal.
Rights and requirements regarding these other assistance animals are where the issue gets murkier, leading companies and public entities to ask exactly how much they must accommodate, and how much they want to.
As long as you're doing the right thing, respecting your guests when they come in, giving them the benefit of the doubt, going with the mindset that, as long as the animal is in control, it's ok, then you're going to be in compliance with most of your ordinances and you're going to make your guests happy.
Airports and airlines present a logical ground zero on this issue—with the overall volume of customers and the toll travel takes on some passengers, from increased stress to fear of confined spaces or heights, there are many legitimate needs for both service and emotional support animals in such settings. The ADA, industry-specific regulation like the ACAA, and state or municipal ordinances can also add up to a complex compliance challenge for a broad range of enterprises that welcome customers to public spaces, such as restaurants, hotels, retail stores, entertainment venues, government buildings and educational institutions. The associated risks can be unique and require specific consideration. In an office setting, accommodations certainly may be necessary, but the same animal coming in daily is a known entity, posing a very different risk profile than unknown animals that could come in at any time with anyone. The shifting landscape and rising adoption of assistance animals make planning for this more confusing and increasingly pressing to address.
With 540 restaurants across 49 states, staying compliant with this patchwork of provisions could be a significant undertaking for Patrick Sterling, senior director of legendary people and risk management at Texas Roadhouse. But he also thinks a focus on ensuring compliance is the wrong approach, both logistically and strategically. In developing a policy for a company focused on service, he believes it is critical to focus on doing the right thing for customers.
"Instead of trying to [meet legal requirements], why not just go to the larger accommodation? That really gets you in compliance with all of them," he said. "As long as you're doing the right thing, respecting your guests when they come in, giving them the benefit of the doubt, going with the mindset that, as long as the animal is in control, it's ok, then you're going to be in compliance with most of your ordinances and you're going to make your guests happy."
Indeed, he takes a rather liberal view of the issue. "If a customer brought a parakeet in, if the parakeet was in their pocket, not a problem. If the parakeet's on the table, eating food, not appropriate," he said. "As long as they're not being disruptive or doing things that would be considered inappropriate, we really don't have an issue with it."
Jay Gates, director of risk management at RMH Franchise Holdings, which operates 163 Applebee's locations across 15 states, takes a slightly less expansive view of the extent of accommodation and noted that, as some of the more "alternative" emotional support animals continue to make headlines, he expects to see companies "dial back their policies allowing comfort animals." That being said, like Sterling, he believes compliance with the ADA and local ordinances should be about accommodation and trust in customers, guided by common sense.
"We don't want to infringe upon our guests, so we don't require any certification or anything like that—it's usually fairly obvious when someone presents with a true service animal," Gates said. When it comes to carrying this out in practice, he added, they advise employees that, "as long as an animal comes in and is not disruptive and is clearly providing some kind of assistance, we let it go."
The ADA requires that a service animal be under the control of its handler, and a business can ask a person with a disability to remove the animal if it engages in sufficiently disruptive behavior, such as uncontrolled barking or jumping on other people. While his Applebee's locations retain this right, Gates reports they have not experienced incidents where enforcement was necessary. "Typically, these animals are extremely well-trained and well-behaved—oftentimes, I would argue, they're better behaved than some children in our restaurants," he said.
The rigid behavioral standards required of a service dog often relieve most risk they could conceivably pose. Service dogs are required to be housebroken, vaccinated, physically controlled and quiet—indeed, excessive or uncontrolled barking can preclude a dog from ever being certified to begin with. While this level of training typically eliminates most legitimate cause for concern, for those who may worry about the impact of having animals in a food service setting, Sterling noted that the ADA always supersedes any local health code. Both Sterling and Gates also reported that they have never seen any damages or a claim that would be considered significant, and both said their franchises receive only a modest number of customer relations calls on the issue.
Our job is to provide legendary service, not to get into whether it's a disability or not. Our expectation is to focus on the behavior of the animal and, by extension, the guest. As long as everybody's in control, we're ok with it.
Increasing use of assistance animals has led both customers and employees to be more aware and accepting in practice, which both believe has helped limit issues. Customers tend to understand why a dog is there and not to touch it, Gates said. In 14 years with Texas Roadhouse, Sterling said he has seen a reduction in calls from locations asking about the issue, which he credits to both exposure and rigorous and regular training throughout the organization, from corporate staff to hourly restaurant workers.
Sterling also noted an evolution in the types of queries from staff, moving from whether assistance animals are allowed in their restaurants to what he called questions of the "low disability threshold" regarding emotional support animals. In addressing such new questions, Sterling advises, "We don't want to get into that—it's not our game. Our job is to provide legendary service, not to get into whether it's a disability or not. Our expectation is to focus on the behavior of the animal and, by extension, the guest. As long as everybody's in control, we're ok with it."
Implementing a Policy
Such assessment guidance gets at, arguably, the greatest risk, which comes not from allowing assistance animals in, but from the actual implementation of accommodation policies by customer-facing employees. An employee trying to ascertain whether an animal is a service animal that must be accommodated, for example, could easily veer from verification to violation of the ADA. Under federal law, places of public accommodation cannot ask a customer about their disability, but they may ask if a dog is a service dog required because of a disability (not what disability or if the person is disabled), and what specific tasks the service dog has been trained to perform.
While none of his clients have faced a situation that actually resulted in a claim, Hunter Mock, managing director of Wortham Insurance and Risk Management in San Antonio, reported he has seen close calls and at least one threatened lawsuit based on Title III requirements in a hotel setting. Ultimately, this incident came down to a training issue—an employee at the front desk asked to see certification to accommodate a service dog, not realizing such a request was based on an outdated policy that was not ADA-compliant.
This "wake-up call" has prompted him to advise other clients to be alert for similar situations and to assess and update their policies and training procedures. "The policies should outline what a 'service animal' is, where service animals can go, who is allowed to have a service animal and how to handle any cleanup fees," he said. It is also important to avoid the potential perception of isolation, he noted, as individuals with disabilities cannot be precluded from areas where other customers are allowed to go.
The Strategic Value of Therapy Animals
Broadening perceptions of the benefits assistance animals offer present not only questions of reasonable or required accommodation, but also questions of strategic adoption. Beyond complying, many enterprises are actively deploying assistance animals, hoping to harness the benefits.
This duality is most apparent at airports: While airlines are cracking down on personal emotional support animals, many airlines and airports have also been bringing more animals in, adopting pet therapy programs to help calm stressed travelers. More than 40 airports in the United States host therapy animal programs, including the CLT Canine Crew in Charlotte, the ironically named Canine Animal Therapy Squad (CATS) in Denver, Los Angeles International's Pets Unstressing Passengers (PUP), San Diego's Ready, Pet Go program, and San Francisco's daily Wag Brigade. Airports in San Francisco and Albany even have therapy pigs—LiLou and Bacon Bits, respectively.
In October 2017, Dallas/Fort Worth International Airport launched the K9 Crew, a pet therapy program that has already grown from 13 to 37 therapy dogs.
"Flying is very stressful, as everybody knows, and this was one of our outreach efforts to really focus on the customer and drive a positive customer experience when flying through DFW," said Michael Yip, the airport's vice president of risk management. "Based on a couple of studies and what we've seen at a couple of other airports, we recognized that this is a very easy way for us to kind of soothe the traveling experience. It's part of a larger-scale program to improve the customer experience and help as we strive to be number one from a customer experience and industry recognition perspective."
Indeed, these initiatives can have a large impact relative to their ease and scale. With accommodations like relief areas already in place for other working dogs in the airport and trained handlers who volunteer to bring the therapy dogs in, there are few discrete financial costs. Each dog in San Diego's "Ready, Pet Go" program reportedly interacts with about 200 individual travelers in the course of a two-hour shift, and that is to say nothing of the publicity or social media impact.
At DFW, risk management has played a key role in crafting and running a successful therapy animal program, from centralizing communication among different groups across the enterprise to ensuring comprehensive safety and insurance policies are in place. Yip's team identified most potential issues up front by engaging various law enforcement and airport stakeholders in a thorough risk assessment process. The airport already hosts working dogs that are brought in by the TSA and the Texas Department of Public Safety, and as the temperaments and responsibilities of detection dogs and service or support dogs are so fundamentally different, they needed to establish protocols to keep these groups separate. The airport oversees communication and scheduling, for example, of planned TSA activity in a given terminal and any animal ambassador visits.
Beyond interaction among animals, Yip was concerned about ensuring safety of people interacting with the different groups of dogs, as the admittedly minor concern about bites presents one of the most concrete risks. To that end, branding and visibility have functioned as both a publicity tool and a risk mitigation measure, he said. Grey vests worn by the K9 Crew function as distinct uniforms, and the active social media promotion around therapy dog visits helps raise both excitement and awareness.
These measures and broader public education overall have helped create a kind of "inherent risk control," Yip believes. People better understand what assistance animals do and which animals to leave alone, and the owners of service and emotional support animals tend to understand the rules and how to monitor and protect their animals in a busy public space.
The experienced handlers who operate such programs also control risk for customers and the airport alike. DFW's program is membership-based, so any individual who wants to take part must to be affiliated with a national therapy dog association or pet therapy program, which also has minimum insurance requirements, and the airport has one master contract with the association. As with other vendor agreements, he engaged the airport's liability insurers to review coverage related to third parties and check for any exclusions under current policies.
"We partner with this organization that manages it, so everyone has gone through their training and been vetted and the organization makes sure they have insurance in place, and we contract with the one entity and say, 'these are the rules of engagement,' and we endorse it and brand it and do everything from that perspective," Yip explained. "It's no different than another contract with a vendor, basically."
As DFW's program is part of a broader customer experience initiative, it is a bit too early to benchmark its overall results. However, the three-fold increase in participation in the program so quickly reflects its initial success, Yip said, and the tremendous amounts of positive feedback and customer engagement are clear from even a cursory look at the airport's social media.
"I think a lot of people are seeing the kind of brand and reputation enhancements these programs can bring as well," Yip said. "Particularly with dogs, it's almost like tapping into this sort of underground, feel-good movement. It's something a lot of my colleagues have been talking about and we've had a number of inquiries because our program has gotten quite a lot of press, so I wouldn't be surprised if you see more airports starting similar kinds of programs."
← The Risks of High-Tech Trash
Risk Management of Technology Risks Lagging, Survey Finds →


text:
Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy
THOUSAND OAKS, Calif., June 24, 2011 /PRNewswire via COMTEX/ --
Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Vectibix® (panitumumab) be approved for use in the European Union (EU) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy (excluding irinotecan) for patients with wild-type KRAS metastatic colorectal cancer (mCRC), following a successful re-examination procedure by Amgen.
"This opinion, for which a final European Commission decision is pending, is a welcome step forward and one that may lead to additional treatment options for patients facing an aggressive disease with limited treatment options," said Willard H. Dere, M.D., senior vice president and international chief medical officer at Amgen. "Studies have shown that patients taking Vectibix in combination with chemotherapy have a greater chance of living longer without their disease getting worse, in a landscape where few targeted agents have been shown to be effective when used with chemotherapy."
Data from studies 20050203 (PRIME) and 20050181 ('181) showed that adding Vectibix to either FOLFOX or FOLFIRI chemotherapy improved progression-free survival (PFS) versus chemotherapy alone for patients with wild-type KRAS mCRC. Additionally, the overall response rate (ORR) of Vectibix plus chemotherapy was higher than chemotherapy alone. Although numerically greater, the improvement in median overall survival (OS) did not achieve statistical significance in the Vectibix arm of either trial.(i)
The PRIME study evaluated Vectibix (6.0 mg/kg every two weeks) plus FOLFOX versus FOLFOX alone in patients with wild-type KRAS mCRC and found that Vectibix plus FOLFOX significantly improved PFS versus FOLFOX alone (median 9.6 months versus 8.0 months, hazard ratio (HR) 0.80; 95 percent confidence interval (CI): 0.66-0.97; p=0.02).(i) Additionally, combining Vectibix with FOLFOX resulted in numerically greater OS versus FOLFOX alone (median 23.9 months versus 19.7 months, HR 0.83; 95 percent CI: 0.67-1.02), although this was not statistically significant (p=0.072).(i) The ORR achieved with Vectibix plus FOLFOX was higher than FOLFOX alone (55 percent versus 48 percent).(i)
The '181 study showed that adding Vectibix (6.0 mg/kg every two weeks) to FOLFIRI chemotherapy improved median PFS by two months in patients with wild-type KRAS mCRC compared to FOLFIRI alone (median 5.9 months versus 3.9 months; HR 0.73, 95 percent CI: 0.59-0.90; p=0.004). Additionally, the Vectibix combination more than tripled the ORR compared to FOLFIRI alone (35 percent versus 10 percent). Though quantitatively greater (14.5 months versus 12.5 months, HR 0.85), the improvement in median OS (co-primary endpoint) did not achieve statistical significance in the Vectibix arm of the trial (p=0.12).(ii)
Adverse event rates included known toxicities associated with anti-epidermal growth factor receptor (EGFR) therapy, such as rash, diarrhea, and hypomagnesemia. Vectibix-related grade 3/4 infusion reactions were reported in less than one percent of patients. (i) In patients with mutated KRAS tumors, outcomes were inferior for those receiving Vectibix plus FOLFOX versus FOLFOX alone.(ii iii) Vectibix should only be used in those patients in whom wild-type KRAS status has been confirmed, because of the worse outcomes in patients with mutated KRAS tumors treated with FOLFOX.
The Amgen PRIME and '181 studies were the first Phase 3 studies to prospectively analyze the effect of an EGFR inhibitor based on KRAS status in patients with mCRC.
Vectibix is already approved and established in 40 countries as a monotherapy treatment for patients with wild-type KRAS mCRC, when standard chemotherapy is no longer effective. In the United States (U.S.), Vectibix received accelerated approval in September 2006 as a monotherapy for the treatment of patients with EGFR-expressing mCRC after disease progression on or following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens. The use of Vectibix is not recommended in patients whose tumors have KRAS mutations in codon 12 or 13. In Japan and Israel, Vectibix is also approved for use in combination with chemotherapy for patients with wild-type KRAS mCRC.
About KRAS
Results from studies performed over the last 25 years indicate that KRAS plays an important role in cell growth regulation. In mCRC, EGFR transmits signals through a set of intracellular proteins. Upon reaching the nucleus, these signals instruct the cancer cell to reproduce and metastasize, leading to cancer progression.(iv) Anti-EGFR antibody therapies work by inhibiting the activation of EGFR, thereby inhibiting downstream events that lead to malignant signaling. However, in patients whose tumors harbor a mutated KRAS gene, the KRAS protein is always turned "on," regardless of whether the EGFR has been activated or therapeutically inhibited. KRAS mutations occur in approximately 40 to 50 percent of mCRC patients.(v vi)
About Colorectal Cancer
Colorectal cancer is the third most common cancer worldwide in men and the second most common in women. In 2008, approximately 1.23 million cases of colorectal cancer were diagnosed globally.(vii) In 2008, there were an estimated 333,330 new cases of colorectal cancer in the EU.(viii)
About Vectibix
Vectibix is the first fully human anti-EGFR antibody approved by the U.S. Food and Drug Administration (FDA) for the treatment of mCRC. Vectibix was approved in the U.S. in September 2006 as a monotherapy for the treatment of patients with EGFR-expressing mCRC after disease progression on or following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.
The effectiveness of Vectibix as a single agent for the treatment of EGFR-expressing mCRC is based on PFS. More than half of patients who receive Vectibix monotherapy respond to treatment with an average six month PFS benefit. Currently no data are available that demonstrate an improvement in disease-related symptoms or increased survival with Vectibix.
Retrospective subset analyses of mCRC trials have not shown a treatment benefit for Vectibix in patients whose tumors had KRAS mutations in codon 12 or 13. Use of Vectibix is not recommended for the treatment of mCRC with these mutations.(ix)
In December 2007, the European Commission granted a conditional marketing authorization for Vectibix as a monotherapy for the treatment of patients with EGFR-expressing mCRC with non-mutated (wild-type) KRAS after failure of fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.(x) Vectibix has been launched in more than 30 European countries, Russia, Israel, Australia, Canada and Japan. Applications in the rest of the world are pending.
Important U.S. Product Safety Information
WARNING: DERMATOLOGIC TOXICITY and INFUSION REACTIONS
Dermatologic Toxicity: Dermatologic toxicities occurred in 89 percent of patients and were severe (NCI-CTC grade 3 or higher) in 12 percent of patients receiving Vectibix monotherapy. [See Dosage and Administration (2.1), Warnings and Precautions (5.1), and Adverse Reactions (6.1)].
Infusion Reactions: Severe infusion reactions occurred in approximately one percent of patients. Fatal infusion reactions occurred in postmarketing experience [See Dosage and Administration (2.1), Warnings and Precautions (5.2), and Adverse Reactions (6.1, 6.3)].
The most common adverse events of Vectibix are skin rash with variable presentations, hypomagnesemia, paronychia, fatigue, abdominal pain, nausea, and diarrhea, including diarrhea resulting in dehydration.
Important European Product Safety Information
For full prescribing information please see the Summary of Product Characteristics.
Vectibix is indicated as monotherapy for the treatment of patients with EGFR-expressing, mCRC with nonmutated (wild-type) KRAS after failure of fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.
Vectibix is contraindicated in patients with a history of severe or life-threatening hypersensitivity reactions to the product and in patients with interstitial pneumonitis or pulmonary fibrosis.
Other common adverse events of special importance associated with Vectibix and/or EGFR monoclonal antibody therapies include dermatologic-related reactions, pulmonary complications, electrolyte disturbances and infusion-related reactions (including rare reports with fatal outcome). These events should be monitored carefully, see Summary of Product Characteristics for information on appropriate management of these adverse events. Acute renal failure has been observed in patients who develop severe diarrhoea and dehydration.
Vectibix should not be used in combination with IFL [bolus 5-fluorouracil (500 mg/m2), leucovorin (20 mg/m2) and irinotecan (125 mg/m2)] or in combination with bevacizumab containing chemotherapy.
Vectibix should not be administered in combination with oxaliplatin-containing chemotherapy to mCRC patients with mutant KRAS tumors or for whom KRAS tumor status is unknown.
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit http://www.amgen.com.
This news release contains forward-looking statements that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and most recent periodic reports on Form 10- Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business. Unless otherwise noted, Amgen is providing this information as of June 24, 2011 and expressly disclaims any duty to update information contained in this news release.
No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.
In addition, sales of our products are affected by the reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.
The scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. FDA, European Medicines Agency (EMA) or similar regulatory bodies for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA, EMA or similar regulatory bodies can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the approved labeling for the products, and not the information discussed in this news release.
CONTACT: Amgen
Carrie Deverell: +41 41 3690 308 (E.U. media)
Christine Regan: +1 805-447-5476 (U.S. media)
Arvind Sood: +1 805-447-1060 (investors)
(Logo http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)
(i) Peeters, M et al. Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer. J Clin Oncol 28, 2010.
(ii) Adverse event rates were comparable across arms with the exception of known toxicities associated with EGFR therapy such as rash, diarrhea and hypomagnesemia. Vectibix-related grade 3 infusion reactions were reported for two patients (less than one percent).
(iii) In general, adverse events rates were comparable across arms with the exception of known toxicities associated with anti-epidermal growth factor receptor (EGFR) therapy such as rash, diarrhea, and hypomagnesemia. Vectibix-related grade 3/4 infusion reactions were reported in less than one percent of patients.
(iv) Malumbres, M. and Barbacid, M. RAS oncogenes: the first 30 years. Nature Reviews Cancer. 3:459-65, 2003.
(v) Karapentis C, S. Snell, L, E. The Laboratory Assessment of KRAS Mutation Status in Colorectal Cancer. Asia, Pacific Journal of Oncology and Hematology. 2010.
(vi) Friday BB and Adjei AA. K-ras as a target for cancer therapy. Biochim. Biophys. Acta 1756: 127-144, 2005
(vii) Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010
(viii) Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010 Mar; 46(4):765-81. Epub 2010 Jan 29.
(ix) Vectibix (panitumumab) [prescribing information]. Thousand Oaks, Calif: Amgen; 2011.
(x) Vectibix (panitumumab) SPC. Thousand Oaks, Calif: Amgen; 2011


The VH1 Hip Hop Honors Tour, in its debut year, comes to Rams Head Live Sunday night. With a style that fuses rock with soul and hip hop, The Roots will headline the show. Rap legends MC Lyte and Big Daddy Kane, both former honorees, will also perform. Doors open at 7 p.m., and the show starts at 8:30 p.m. Rams Head is at 20 Market Place. Tickets are $35 and $75. Call 410-244-1131 or go to ramsheadlive.com.


text:
Q: Request between client and API. Get or Post? Is the information protected by the certificate? Ignore the following, go to "@edit2"
i read a lot about SSL certificates but still i can't figure out the following:
I have a program that does a POST to my API, how do i make this program do it using the Certificate, i mean to protect the information sent.
Do i have to include the certificate in the client? or when it does the post it first asks the server for the certificate?
In the case that it should include the certificate, isn't that unsafe?
Because stackoverflow asks me to say the following:
I already tried reading a lot about SSL certificates, this https://medium.freecodecamp.org/https-explained-with-carrier-pigeons-7029d2193351 helped me a lot but still i don't get how it works for my case.
If there is any way i can try, any website that i can easy use to make an HTTPS Post, please tell me.
Thanks in advance
@edit1: To be honest, after posting this i found the right words to search on google and i found this post:
https://security.stackexchange.com/questions/110621/ssl-newbie-does-https-client-also-need-a-certificate
But i wanted to know if this applies for the following case:
file.exe doing POST to api on server (sending username and password), server answering the file.exe with "you are logged in" or "nop, wrong pw/user".
If i have SSL enabled on my page, will my .exe send the information in plain-text? and, will my API answer with plain-text?
Should i do this with POST or GET? i read that POST is better because it sends the information on the Body instead of the URL, but will the answer from the API be protected by the certificate in this case?
Thanks in advance.
@edit2: Editing 1 more time because thanks to @Ladislav Louka (idk the right way to tag someone) i found that i can intercept the packets and check that this by myself.
My last question is:
Do i need to include the certificate on the client to make everything secure? I mean, does the server really need to know if it's my client that is doing Requests? Couldn't this be unsafe because the certificate could be stolen? like the secret key? and then used for another app to do a brute force attack on my page?

redpajama_set_name: RedPajamaStackExchange


Fern is a Solicitor in our Commercial Real Estate team, dealing with all elements of commercial property. In particular, Fern deals with Residential Development matters for housebuilders, residential developers and landowners.
Fern also provides Real Estate advice and assistance in respect of corporate dental practice acquisitions and sales.
Fern qualified into the Commercial Real Estate team in October 2017 after completing her training in the Liverpool office of a large national law firm. She studied Law at the University of York before completing her LPC (MA with Business) at BPP Law School.
Is the Land Registry moving to "Digital Street"?


See demonstrations, visit booths, get free giveaways, win prizes, and enjoy healthy snacks!
Dalhousie is committed to providing a safe working and learning environment.
YOUR health and safety is important!
The Expo has something of interest for everyone. Check out our growing list of booths and attractions.
4. Johnson Insurance. Enter for a chance to win an iPad mini!
7. Student Health Services: Free Flu Immunizations!
22. Food Services Dietician, Angela Emmerson. Offering homemade local soup samples!


text:
Q: How to correctly and efficiently unwrap these optionals? Yes, it's another optionals question... :(
Every time i think i'm starting to get a good grasp on optionals, Xcode throws me a error fix suggestion for unwrapping.  The following block of code uses all of Xcodes error fixes.  But i dont think it's the correct way of doing this.
var btAdd = [SKSpriteNode]()
var btLose = [SKSpriteNode]()

...

let touchedNodes = self.nodes(at: pos)

for node in touchedNodes{
    if btAdd.contains((node as? SKSpriteNode)!) {
        let index = Int(String(describing: node.name?[(node.name?.endIndex)!]))
        node.isHidden = true
        btLose[index!].isHidden = false
        var dogTeam = defaults.array(forKey: "dogTeam") as! [Int]
        dogTeam.append(index!)
        defaults.set(dogTeam,forKey: "dogTeam")
    }
}

I started to do...
if let node as? SKSpriteNode{
   if btAdd.contains(node){
      ...
   }
}

But I wasn't sure on that either.
I'm looking for some guidance on the absolute "correct" way to do this block of code.  Not just the .contains portion, but the unwrapping of index and the UserDefaults array.

A: Actually, the last part of your code seems fine. It's just the first part that needs a bit of tweaking. And the thing that you're "starting to do" is fine as well, but here is another version:
for node in touchedNodes where node as? SKSpriteNode != nil &&
    btAdd.contains(node as! SKSpriteNode){

If you use the above, you don't even need the if statement in the loop.
You seem to be quite confused with where to force unwrap and where not to. Just remember that you only force unwrap when you are absolutely sure that the thing you're unwrapping cannot be nil.
This line looks quite bad:
let index = Int(String(describing: node.name?[(node.name?.endIndex)!]))

It seems like you want to get the last character of the node's name and turn it into an int. Since you first checked whether the node is in an array, I think it is safe to force unwrap here. (I assume all the nodes in the array has a name ending with a number) Also, to get the last character, just do str.character.last:
let index = Int(node.name!.characters.last!.description)!

A: You can also wrap your optionals in an if statement which removes the "optionalness" of them. First example index becomes non optional whenever I reference it
    if let index = Int(spinButton.name!) {
        let something = someArray[index]
    }

Your way... index2 is always optional every time it gets referenced
    let index2 = Int(spinButton.name!)
    let something = someArray[index2!]


After a month of use the problem I'm having with the Samsung S10 is its bezeless screen. When I go on any web site or THvid, Facebook or Twitter the phone freezes or goes back to previous web sites I was on if any part of my hand touches the side of the S10's bezeless screen....this is very annoying!!!!! Bezeless screens do not work because when holding the S10 phone users have got to make sure their hand does not touch the edge of the screen. When the S10 has a case on it's fine....without a case it's a nightmare to use and it can make users angry. I can hold the phone in one hand it works fine but there is a big risk of dropping the phone and cracking the screen. For a fully functional phone the S10 needs a case. Samsung needs to go back to having bezels around the edges of their screens.


Dr Ahmed Saad Zaghloul completed his MBBCH and MS(Urology) from Ain Shams University, Cairo Egypt. He followed this with an MRCS from England and a Diploma in Laparoscopic Urologic Surgery, IRCAD from Strasbourg, France.
Dr Ahmed has extensive experience in endoscopic management of stone disease laparoscopic ablative and reconstructive urological procedures management of urological cancers, advanced urodynamics, female urology and neurourology urethral reconstructive surgery holmium laser enucleation of prostate (HOLEP) apart from general urology. He is also trained for CPR and Basic life support (BLS) accredited by the American Heart Association.
His experience as a Specialist Urologist spans 9 years in Cairo, Egypt followed by 14 years in Saudi Arabia, 2 years in Kuwait and 1 year in Dubai. He recently joined NMC Healthcare.
He is a member of the European Association of Urology and International Continence Society. He has many publications and scientific activities to his credit.
M B B C H, M S( Urology), M R C S, Diploma in Laparoscopic Urologic Surgery.


Why Buy Bravado Designs Leotard Back?
The Bravado Designs Body Silk Seamless Nursing Bra 1401 features nursing clips that lie flat under clothing and removable foam inserts (cookies) . Bravado Designs' Body Silk Seamless Nursing Bra has a leotard back.
Fits as expected. I used their sizing chart to determine the size I bought. Comfortable, I wear it to sleep in and it doesn't bother me at all.


text:
GST Compliance Likely to Be More Stringent
With almost two years into implementation of the GST, the system is going to be more stringent and competent with regard to tax evasion as numerous complaints of tax evasion in different B2B segments are being received by the department. The wood panel industry is also under their scanner due to be marked as an unorganized trade. The government is aiming on anti - evasion measures to shore up revenue and increase compliance and the council has formed two officers' committees, one to look into the feasibility of introducing e - invoice system and the other to streamline generation of invoices and easing compliance burden. The committee will finalize an interim report by July.
According to the media reports, the GST officials are developing a system for the businesses above a certain turnover which will have to generate 'e-invoice' on government or GST portal for their every sales, in the same way the E - way bill is being generated.The officials of the concerned departments say that there are many complaints received regularly against small business entities dealing in various goods and articles including wood panel, hardware, sanitary ware, furniture, electrical goods etc. They have received several complaints with regard to charging of GST by entities who have not been filing returns as well. As the number of complaints is very large, the tax department is developing a mechanism to find out the quantum of possible tax evasion and refer them to field offices for follow - up actions, according to the sources.
In the new system after implementation, the businesses would be provided a software which will be linked to GSTN or a government portal for generating e-invoice. They will get a unique number for every electronic invoice generated which can be matched in the sales return and taxes paid. The proposed system of e-invoice will eventually replace the requirement of generation of e-way bill for movement of goods, as invoices would be generated through a GSTN.
Currently, e-way bill is required for moving goods exceeding Rs 50,000. The official further said that once full e-tax invoice starts getting generated, it would significantly ease burden of return filing by businesses as invoice wise data would be auto-populated in the return forms. "The newly formed committees have to study global models especially in the countries like Latin America, South Korea and Europe. They will also look at ways to incentivise businesses to adopt the method of e-invoice generation," the official said.
There are over 1.21 crore registered businesses under the GST, of which 20 lakh are under composition scheme. For 2019-20, the government proposes to collect Rs 6.10 lakh crore from Central GST and Rs 1.01 lakh crore as compensation scheme. The Central GST collection in 2018-19 fiscal was Rs 4.25 lakh crore, while compensation cess was over Rs 97,000 crore.
GSTN
Central GST
Interzum 2019, Through the Eyes of the Ply Reporter
IIR & WADe ASIA: India's First Conference & Exhibition ...
REHAU Showcased Amazing Designs and Renovation


Marshall went to her spinning class.
Does Hsuan know he was adopted?
She dismissed what Stan was saying.
Jayesh's a beginner, but he catches on fast.
What were you and Kieran doing yesterday?
You should probably tell Jeffie when he needs to be here.
Brandi will be asking us to help.
Heinz's very much in control of the situation.
Manavendra seems to be enjoying all this.
Please don't tell Sanjay I told you.
Mehrdad put the guitar case down so he could hug Michael.
Spock believes that he has been physically touched by a ghost.
Vadim took very good care of Karen.
Knut made the announcement Monday.
Vern keeps his important papers in a brown leather case.
Jarl doesn't sound very optimistic.
We wanted to ask Josh some questions, but he's gone.
Troy says not to worry.
Ramon can't decide what to order.
Nobody cares what happens to Louise.
Saify may not have known Israel would be here.
Santa doesn't know how to eat with chopsticks.
I carried out Malus's instructions.
Joe slept like a child.
What's this got to do with Yvonne?
Wendy's baby is less than a month old.
Masanao plays golf every weekend.